Old Web
English
Sign In
Acemap
>
authorDetail
>
Marianne de Bruijn
Marianne de Bruijn
MF59
Influenza vaccine
Vaccination
Internal medicine
Medicine
2
Papers
42
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Immunogenicity and Safety of an MF59-adjuvanted Quadrivalent Seasonal Influenza Vaccine in Young Children at High Risk of Influenza-associated Complications: A Phase III, Randomized, Observer-blind, Multicenter Clinical Trial.
2020
Pediatric Infectious Disease Journal
Susanna Esposito
John A. Fling
Kulkanya Chokephaibulkit
Marianne de Bruijn
Janine Oberye
Bin Zhang
Jeanique Vossen
Esther Heijnen
Igor Smolenov
Show All
Source
Cite
Save
Citations (3)
Efficacy, immunogenicity, and safety evaluation of an MF59-adjuvanted quadrivalent influenza virus vaccine compared with non-adjuvanted influenza vaccine in children: a multicentre, randomised controlled, observer-blinded, phase 3 trial
2018
The Lancet Respiratory Medicine
Timo Vesikari
Judith Kirstein
Grace Devota Go
Brett Leav
Mary Ellen Ruzycky
Leah Isakov
Marianne de Bruijn
Janine Oberye
Esther Heijnen
Show All
Source
Cite
Save
Citations (39)
1